| |
Latest 10 SEC filings (by transaction date) for ARWR within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Hamilton James C | Direct Ownership | Common Stock | S - Open market or private sale | -6,000 | $28.03 |
Mar 20/24 | Mar 20/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $27.50 |
Mar 20/24 | Mar 19/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $28.00 |
Mar 20/24 | Mar 18/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $27.49 |
Mar 18/24 | Mar 18/24 | Lu Hongbo | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 8/24 | Mar 6/24 | Myszkowski Kenneth Allen | Direct Ownership | Common Stock | S - Open market or private sale | -40,000 | $35.19 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -57,499 | |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | S - Open market or private sale | -19,730 | $32.71 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | S - Open market or private sale | -37,769 | $32.16 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 57,499 | $14.54 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ARWR within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Hamilton James C | Direct Ownership | Common Stock | S - Open market or private sale | -6,000 | $28.03 |
Mar 20/24 | Mar 20/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $27.50 |
Mar 20/24 | Mar 19/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $28.00 |
Mar 20/24 | Mar 18/24 | Lu Hongbo | Direct Ownership | Common Stock | P - Open market or private purchase | 1,000 | $27.49 |
Mar 18/24 | Mar 18/24 | Lu Hongbo | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 8/24 | Mar 6/24 | Myszkowski Kenneth Allen | Direct Ownership | Common Stock | S - Open market or private sale | -40,000 | $35.19 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -57,499 | |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | S - Open market or private sale | -19,730 | $32.71 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | S - Open market or private sale | -37,769 | $32.16 |
Feb 2/24 | Jan 31/24 | Anzalone Christopher Richard | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 57,499 | $14.54 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |